中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2008年
11期
993-997
,共5页
潘金顺%庄辉%吴超%周锦勇%唐勤%周乙华
潘金順%莊輝%吳超%週錦勇%唐勤%週乙華
반금순%장휘%오초%주금용%당근%주을화
戊型肝炎病毒%ORF2多肽%二聚体%抗原性%点突变
戊型肝炎病毒%ORF2多肽%二聚體%抗原性%點突變
무형간염병독%ORF2다태%이취체%항원성%점돌변
Hepatitis E virus%ORF2 polypoptide%Homodimer%Antigenicity%Mutagenesis
目的 研究4型戊型肝炎病毒(hepatitis E virus,HEV)开放阅读框架2(open readingframe 2,ORF2)编码的多肽二聚体特性和抗原性特征.方法 从患者血清克隆HEV ORF2基因,在大肠杆菌中表达不同长度的ORF2多肽,并表达点突变多肽,纯化后在SDS-PAGE不同条件下分析二聚体特性,同时用Westem blot分析其抗原性特征.结果 由459~607位氨基酸构成的ORF2多肽能形成二聚体,而在氨基端截短13个氨基酸或在羧基端截短13个氨基酸均不形成二聚体,562位天冬酰胺、595位异亮氨酸分别突变后在SDS作用下仅以单体存在.Westem blot显示,抗-HEV仅与二聚体的ORF2多肽反应,而不与单体ORF2多肽或截短肽反应.结论 4型HEV ORF2多肽形成二聚体必须含有459~607位氨基酸,其中562位和595位氨基酸突变能影响二聚体的稳定性.该多肽的抗原性取决于二聚体结构.
目的 研究4型戊型肝炎病毒(hepatitis E virus,HEV)開放閱讀框架2(open readingframe 2,ORF2)編碼的多肽二聚體特性和抗原性特徵.方法 從患者血清剋隆HEV ORF2基因,在大腸桿菌中錶達不同長度的ORF2多肽,併錶達點突變多肽,純化後在SDS-PAGE不同條件下分析二聚體特性,同時用Westem blot分析其抗原性特徵.結果 由459~607位氨基痠構成的ORF2多肽能形成二聚體,而在氨基耑截短13箇氨基痠或在羧基耑截短13箇氨基痠均不形成二聚體,562位天鼕酰胺、595位異亮氨痠分彆突變後在SDS作用下僅以單體存在.Westem blot顯示,抗-HEV僅與二聚體的ORF2多肽反應,而不與單體ORF2多肽或截短肽反應.結論 4型HEV ORF2多肽形成二聚體必鬚含有459~607位氨基痠,其中562位和595位氨基痠突變能影響二聚體的穩定性.該多肽的抗原性取決于二聚體結構.
목적 연구4형무형간염병독(hepatitis E virus,HEV)개방열독광가2(open readingframe 2,ORF2)편마적다태이취체특성화항원성특정.방법 종환자혈청극륭HEV ORF2기인,재대장간균중표체불동장도적ORF2다태,병표체점돌변다태,순화후재SDS-PAGE불동조건하분석이취체특성,동시용Westem blot분석기항원성특정.결과 유459~607위안기산구성적ORF2다태능형성이취체,이재안기단절단13개안기산혹재최기단절단13개안기산균불형성이취체,562위천동선알、595위이량안산분별돌변후재SDS작용하부이단체존재.Westem blot현시,항-HEV부여이취체적ORF2다태반응,이불여단체ORF2다태혹절단태반응.결론 4형HEV ORF2다태형성이취체필수함유459~607위안기산,기중562위화595위안기산돌변능영향이취체적은정성.해다태적항원성취결우이취체결구.
Objective To characterize the dimerization and the antigenicity of the ORF2 polypep-tide of hepatitis E virus (HEV, genotype 4). Methods HEV ORF2 gene was cloned from the serum of a patient with hepatitis E. The genotype was determined by sequencing. Three ORF2 polypeptides differing in size and other polypeptides with point mutations were produced in E. coli. The recombinant polypeptides were purified and analyzed by SDS-PAGE and Western blot. Results The ORF2 polypeptide containing 459-607 amino acid formed homedimer even in 8 mol/L urea. The truncated polypeptides containing amino acid 472-607 or 459-594 formed monomer only. The mutations at amino acid 562 or 595 disrupted the ho-modimer, whereas the mutations at amino acid 476 or 580 did not. Anti-HEV from hepatitis E patients only reacted with the homodimer form of the polypeptide 459-607 and did not react with monomer or tnmcated pol-ypeptides. Conclusion The amino acid 459-607 of HEV ORF2 is essential for dimerization of the ORF2 polypeptide. Residues at amino acid 562 and 595 are critical for the dimerization. The antigenicity of the polypeptide 459-607 mainly depends on its homodimer form.